Clinical Trial Update: The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of pirfenidone in patients with heart failure with preserved ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Cardiac Failure | Phase 2 | Status: COMPLETED